2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide

C25H21BrN6OS2 — CID 18808698

IUPAC2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide
SMILESO=C(CSc1nnc2c3cc(Br)ccc3n(Cc3ccccc3)c2n1)Nc1nc2c(s1)CCCC2
InChIInChI=1S/C25H21BrN6OS2/c26-16-10-11-19-17(12-16)22-23(32(19)13-15-6-2-1-3-7-15)29-25(31-30-22)34-14-21(33)28-24-27-18-8-4-5-9-20(18)35-24/h1-3,6-7,10-12H,4-5,8-9,13-14H2,(H,27,28,33)
InChIKeyGBVFQMZUWWRRSJ-UHFFFAOYSA-N
MW565.52 g/mol
LogP5.86
Rot. Bonds6

About 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide

2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide (PubChem CID 18808698) has the molecular formula C25H21BrN6OS2 and a molecular weight of 565.52 g/mol. Its IUPAC name is 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide.

Molecular Properties

Compound Name2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide
PubChem CID18808698
Molecular FormulaC25H21BrN6OS2
Molecular Weight565.52 g/mol
Exact Mass564.04
IUPAC Name2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide
SMILESO=C(CSc1nnc2c3cc(Br)ccc3n(Cc3ccccc3)c2n1)Nc1nc2c(s1)CCCC2
InChIInChI=1S/C25H21BrN6OS2/c26-16-10-11-19-17(12-16)22-23(32(19)13-15-6-2-1-3-7-15)29-25(31-30-22)34-14-21(33)28-24-27-18-8-4-5-9-20(18)35-24/h1-3,6-7,10-12H,4-5,8-9,13-14H2,(H,27,28,33)
InChIKeyGBVFQMZUWWRRSJ-UHFFFAOYSA-N
XLogP5.86
TPSA85.59 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500565.52
LogP ≤ 55.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide?
The IUPAC name of 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide (CID 18808698) is 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide.
What is the SMILES notation for 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide?
The canonical SMILES for 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide is O=C(CSc1nnc2c3cc(Br)ccc3n(Cc3ccccc3)c2n1)Nc1nc2c(s1)CCCC2.
What is the InChIKey of 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide?
The InChIKey is GBVFQMZUWWRRSJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H21BrN6OS2/c26-16-10-11-19-17(12-16)22-23(32(19)13-15-6-2-1-3-7-15)29-25(31-30-22)34-14-21(33)28-24-27-18-8-4-5-9-20(18)35-24/h1-3,6-7,10-12H,4-5,8-9,13-14H2,(H,27,28,33).
What are the key properties of 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide?
2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide has a molecular weight of 565.52 g/mol, XLogP of 5.86, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5-benzyl-8-bromo-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide is sourced from PubChem (CID 18808698), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).